Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03056417
Other study ID # 14X145
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 10, 2017
Est. completion date May 2019

Study information

Verified date September 2020
Source Ohio University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The current project will use the Complete Health Improvement Program (CHIP) as an intervention for patients with chronic pain. CHIP is a nationally recognized program that encourages a diet of whole plant-based foods, moderate exercise, stress reduction, and social support. Patients with chronic pain who enroll in CHIP classes will be monitored and compared to patients with chronic pain who are not enrolled in CHIP classes. It is hypothesized that patients who complete CHIP will have increased telomerase activity and longer relative telomere length at follow-up when compared to those who do not enroll in the program. Chromosomes consist of DNA that contains the genetic makeup of an individual; and telomeres are the caps on these chromosomes that protect them from damage. Telomere shortening occurs normally with aging and once they are too short to replicate cellular death occurs. Telomerase is a ribonucleic protein that counterbalances this shortening by extending the ends of chromosomes. Research has shown that patients with chronic pain may have shorter telomeres relative to others of the same age. This study will investigate this association further.


Recruitment information / eligibility

Status Completed
Enrollment 67
Est. completion date May 2019
Est. primary completion date May 2019
Accepts healthy volunteers No
Gender All
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria: - 40-70 years old - Physician confirmed chronic pain diagnosis for at least 6 months Exclusion Criteria: - Pregnancy - Physical or mental condition that limits ability to provide consent or answer questionnaires

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
The Complete Health Improvement Program
The Complete Health Improvement Program is a nationally recognized program that encourages a diet of whole plant based foods, moderate exercise, stress reduction, and social support.

Locations

Country Name City State
United States Ohio University Athens Ohio

Sponsors (1)

Lead Sponsor Collaborator
Ohio University

Country where clinical trial is conducted

United States, 

References & Publications (4)

Drozek D, Diehl H, Nakazawa M, Kostohryz T, Morton D, Shubrook JH. Short-term effectiveness of a lifestyle intervention program for reducing selected chronic disease risk factors in individuals living in rural appalachia: a pilot cohort study. Adv Prev Med. 2014;2014:798184. doi: 10.1155/2014/798184. Epub 2014 Jan 16. — View Citation

Hassett AL, Epel E, Clauw DJ, Harris RE, Harte SE, Kairys A, Buyske S, Williams DA. Pain is associated with short leukocyte telomere length in women with fibromyalgia. J Pain. 2012 Oct;13(10):959-69. doi: 10.1016/j.jpain.2012.07.003. — View Citation

Li B, Comai L. Requirements for the nucleolytic processing of DNA ends by the Werner syndrome protein-Ku70/80 complex. J Biol Chem. 2001 Mar 30;276(13):9896-902. Epub 2001 Jan 4. — View Citation

Shcherbakova DM, Zvereva ME, Shpanchenko OV, Dontsova OA. [Telomerase: structure and properties of the enzyme, characteristics of the yeast telomerase]. Mol Biol (Mosk). 2006 Jul-Aug;40(4):580-94. Review. Russian. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Telomerase activity changes as a result of lifestyle change Assessed via peripheral blood mononuclear cells Change from baseline telomerase at 3 months
Primary Subjective pain ratings as a function of positive lifestyle modifications Assessed via the Brief Pain Inventory - Short Form. Measures pain intensity from 0 to 10, 10 being pain as bad as you can imagine. Also measures the extent to which pain interferes with daily functioning (0 - 10 possible, with 10 indicating completely interferes). Change from baseline subjective pain at 3 months
Secondary Relative telomere length changes as a result of lifestyle change Assessed via whole blood samples Change from baseline telomere length at 3 months
Secondary Relative telomere length changes as a result of lifestyle change at 1-year follow-up Assessed via whole blood samples Change from 3 month follow-up data of telomere length at 1-year
Secondary Fasting glucose changes as a result of lifestyle change Assessed via whole blood samples Change from baseline fasting glucose at 3 months
Secondary Fasting glucose changes as a result of lifestyle change at 1-year follow-up Assessed via whole blood samples Change from 3 month follow-up data of fasting glucose at 1-year
Secondary Fasting lipid profile (i.e., HDL, LDL, triglycerides) modification as a result of lifestyle change Assessed via whole blood change from baseline fasting lipids at 3 months
Secondary Fasting lipid profile (i.e., HDL, LDL, triglycerides) modification as a result of lifestyle change at 1-year follow-up Assessed via whole blood Change from 3 month follow-up data of fasting lipids at 1-year
Secondary C-reactive protein changes as a result of lifestyle change Assessed via plasma change from baseline C-reactive protein at 3 months
Secondary C-reactive protein changes as a result of lifestyle change at 1-year follow-up Assessed via plasma Change from 3 month follow-up data of C-reactive protein at 1-year
Secondary Overall well-being changes as a result of lifestyle change The RAND-36 item short form survey. High score indicates more favorable health state. Minimum score 0 Maximum score 100. change from baseline overall well-being at 3 months
Secondary Overall well-being changes as a result of lifestyle change at 1-year follow-up The RAND-36 item short form survey. High score indicates more favorable health state. Minimum score 0 Maximum score 100. Change from 3 month follow-up data of overall well-being at 1-year
Secondary Perceived Stress changes as a result of lifestyle change The 14-item Perceived Stress Scale. Minimum score 0 Maximum score 40. Higher scores indicate greater perceived stress. change from baseline perceived stress at 3 months
Secondary Perceived Stress changes as a result of lifestyle change at 1-year follow-up The 14-item Perceived Stress Scale. Minimum score 0 Maximum score 40. Higher scores indicate greater perceived stress. Change from 3 month follow-up data of perceived stress at 1-year
Secondary Depressive symptom changes as a result of lifestyle change Center for Epidemiological Studies Depression Scale. Higher score indicates greater depressed mood. Minimum score 0 Maximum score 60. change from baseline depressed mood at 3 months
Secondary Depressive symptom changes as a result of lifestyle change at 1-year follow-up Center for Epidemiological Studies Depression Scale. Higher score indicates greater depressed mood. Minimum score 0 Maximum score 60. Change from 3 month follow-up data of depressed mood at 1-year
Secondary Perceived social support modification as a result of lifestyle change Multidimensional Scale of Perceived Social Support. Higher score indicates greater perceived social support. Minimum score 1 Maximum score 7. change from baseline perceived social support at 3 months
Secondary Perceived social support modification as a result of lifestyle change at 1-year follow-up Multidimensional Scale of Perceived Social Support. Higher score indicates greater perceived social support. Minimum score 1 Maximum score 7. Change from 3 month follow-up data of perceived social support at 1-year
Secondary Health-Promoting behavior change as a result of lifestyle modification Health-Promoting Lifestyle Profile II questionnaire. Higher score indicate greater health promotion. Minimum score 1 Maximum score 4. change from baseline health promoting behavior at 3 months
Secondary Health-Promoting behavior change as a result of lifestyle modification at 1-year follow-up Health-Promoting Lifestyle Profile II questionnaire. Higher score indicate greater health promotion. Minimum score 1 Maximum score 4. Change from 3 month follow-up data of health promoting behavior at 1-year
Secondary Telomerase activity changes as a result of lifestyle change at 1-year follow-up Assessed via peripheral blood mononuclear cells Change from 3 month follow-up data of telomerase activity at 1-year
Secondary Subjective pain ratings as a function of positive lifestyle modifications at 1-year follow-up Assessed via the Brief Pain Inventory - Short Form. Measures pain intensity from 0 to 10, 10 being pain as bad as you can imagine. Also measures the extent to which pain interferes with daily functioning (0 - 10 possible, with 10 indicating completely interferes). Change from 3 month follow-up data of subjective pain at 1-year
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain